An evaluation of early use patterns to assess the effectiveness of Xeljanz® (tofacitinib citrate) in rheumatoid arthritis: A retrospective non-interventional database study of observational data embedded within Optimising Patient outcome in Australian RheumatoLogy - Quality Use of Medicines Initiative (OPAL-QUMI) (OPal study of xeljanz Effectiveness in RA - OPERA)

Documents

Study protocol

Initial protocol

A3921292 NIS Protocol

Study results

Study results

A3921292 Non-Interventional Study Report Abstract 23 August 2021_Redacted

Study report

Study report

A3921292 Non Interventional Study Report 07 June 2021_Redacted

Other information